The Leukemia & Lymphoma Society of Canada
Dana Lipnicki, CFRE, currently serves as the Business Development & Advancement Manager at The Leukemia & Lymphoma Society of Canada, where the focus is on developing a major gift program and enhancing business relationships nationwide. Prior experience includes the role of Manager of Annual Giving at IWK Foundation, overseeing various giving programs and contributing to a rebranding initiative. As Development Manager at Community Forests International, Dana established an individual fundraising program and fostered collaboration within the team. A brief tenure as a Fundraising Consultant at Sierra Club Foundation involved creating a major donor management system and supporting an annual fundraising event. Previous roles at Ecology Action Centre included Community Giving Manager, where responsibility for diversifying fundraising efforts was held; Membership Coordinator, with a significant increase in membership; and Magazine Advertising Coordinator. Dana holds a Bachelor of Arts in International Development from Dalhousie University, completed in 2013.
This person is not in any teams
The Leukemia & Lymphoma Society of Canada
The Leukemia & Lymphoma Society of Canada (LLSC) is a voluntary health agency dedicated to blood cancer. LLSC funds lifesaving blood cancer research across Canada and worldwide, and provides free information and support services. We won’t stop until there is a cure for leukemia, lymphoma, myeloma, myelodysplastic syndromes and myeloproliferative neoplasms and are able to improve the quality of life of people affected by blood cancers and their families by funding life-enhancing research and providing educational resources, services and support. Our strategy to achieve the mission is based on three areas of focus: research, patient support and advocacy. In 2017, we invested almost $7.4 million in the creation of programs and delivery of services to improve the lives of Canadians affected by blood cancers from coast to coast. This investment included a commitment of over $4.1 million in innovative, life-changing research to accelerate new cancer treatments, therapies, and cures; and $3.3 million towards funding patient services, programs and education across Canada. Everything we do is made possible through the generosity of individuals, corporate partners, and foundations. In the last two decades alone, the Leukemia & Lymphoma Society of Canada has raised $207 million for research and services. We receive no government support.